Erythropoietin (EPO) deficiency and/or resistance, iron deficiencies (resulting from reduced dietary intake, impaired enteral absorption, blood loss), and proteinuria (with loss of transferrin or EPO) are mechanisms leading to anemia development in patients with diabetic kidney disease [41, 42]. The gene discussed is EPO; the disease is anemia.